Logo image
In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc
Journal article   Peer reviewed

In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc

M. Jones, A.H. Peden, C.V. Prowse, A. Gröner, J.C. Manson, M.L. Turner, J.W. Ironside, I.R. MacGregor and M.W. Head
The Journal of Pathology, Vol.213(1), pp.21-26
2007
url
Link to Published Version *Subscription may be requiredView

Abstract

Variant Creutzfeldt–Jakob disease (vCJD) poses a serious risk of secondary transmission and the need to detect infectivity in asymptomatic individuals is therefore of major importance. Following infection, it is assumed that minute amounts of disease‐associated prion protein (PrPSc) replicate by conversion of the host cellular prion protein (PrPC). Therefore, methods of rapidly reproducing this conversion process in vitro would be valuable tools in the development of such tests. We show that one such technique, protein misfolding cyclic amplification (PMCA), can amplify vCJD PrPSc from human brain tissue, and that the degree of amplification is dependent upon the substrate PRNP codon 129 polymorphism. Both human platelets and transgenic mouse brain are shown to be suitable alternative substrate sources, and amplified PrPSc can be detected using a conformation‐dependent immunoassay (CDI), allowing the detection of putative proteinase K sensitive forms of PrPSc.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.52 Neurodegenerative Diseases
1.52.992 Prion Pathogenesis
Web Of Science research areas
Oncology
Pathology
ESI research areas
Clinical Medicine
Logo image